ArticleThe American journal of case reports2025
Comprehensive Cytogenetic Analysis Reveals Mosaicism in Newborn with Negative Prenatal Down Syndrome Screening: A Case Report.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Down syndrome, or trisomy 21, is one of the most common chromosomal disorders associated with intellectual disability. Prenatal screening is a proactive approach to identify fetuses with common chromosomal abnormalities. Mosaicism is one of the causes of false-negative results in prenatal screening for Down syndrome. CASE REPORT We present a case of a newborn with tissue-specific and intercellular mosaicism for trisomy 21. Postnatal karyotyping of phytohemagglutinin-stimulated lymphocytes confirmed trisomy 21 in all analyzed metaphases. However, fluorescence in situ hybridization on unstimulated lymphocyte nuclei and buccal smears revealed mosaicism, with approximately 20% of cells from both tissues displaying disomy for chromosome 21. The intercellular karyotypic discordance observed in this case shows that mosaicism can be more complex than what is detectable by conventional karyotyping, and that it can be related to the biological particularities of the analyzed cells and restriction of a widely used cell division stimulator, rather than to technical limitation. CONCLUSIONS Our findings underscore the critical importance of combining karyotyping with fluorescence in situ hybridization on unstimulated lymphocytes and buccal smear cells to improve the accuracy of cytogenetic diagnosis in newborns with suspected Down syndrome. Such in-depth cytogenetic analyses provide essential information for genetic counseling, research on genotype-phenotype correlations, and evaluation of age-acquired mosaicism and its association with age-related comorbidities in patients with trisomy 21. Comprehensive identification of the biological causes underlying false-negative results in prenatal screening can help overcome the limitations of current technological platforms and support the refinement of diagnostic algorithms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.